Related Experiment Videos
Interferon-gamma receptor expression in chronic hepatitis B virus infection
J Y Lau1, A G Morris, G J Alexander
1Institute of Liver Studies, King's College Hospital, London, United Kingdom.
Journal of Hepatology
|March 1, 1992
Summary
Interferon-gamma (IFN gamma) is less effective than interferon-alpha (IFN alpha) for chronic HBV infection. This study found no difference in IFN gamma receptors on lymphocytes, suggesting receptor levels do not explain the varied responses.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Chronic hepatitis B virus (HBV) infection is a global health concern.
- Interferon-alpha (IFN alpha) shows efficacy, while interferon-gamma (IFN gamma) has limited sustained inhibition of HBV replication.
- The mechanism behind the differential response to IFN alpha and IFN gamma in chronic HBV infection remains unclear.
Purpose of the Study:
- To investigate whether underexpression of the interferon-gamma receptor (IFN gamma-R) on peripheral blood lymphocytes contributes to the reduced efficacy of IFN gamma in chronic HBV infection.
- To compare IFN gamma-R binding characteristics in patients with chronic HBV infection to healthy controls and patients with non-viral chronic liver disease.
Main Methods:
- Utilized radioiodinated recombinant IFN gamma to study IFN gamma binding to peripheral blood lymphocytes.
- Quantified IFN gamma receptor expression and determined dissociation constants (Kd) in patient cohorts and controls.
- Analyzed correlations between IFN gamma-R expression and clinical/virological parameters (transaminases, HBsAg, HBV-DNA, liver histology).
Main Results:
- Peripheral blood lymphocytes from patients with chronic HBV infection, healthy controls, and patients with non-viral chronic liver disease expressed similar numbers of IFN gamma-R.
- The dissociation constant (Kd) for IFN gamma binding was comparable across all groups.
- No correlation was observed between IFN gamma-R expression levels and serum transaminases, HBsAg, HBV-DNA titres, or liver histology.
- In vivo IFN alpha therapy did not enhance IFN gamma-R expression.
Conclusions:
- The data does not support the hypothesis that underexpression of IFN gamma-R on lymphocytes accounts for the differential clinical response to IFN gamma compared to IFN alpha in chronic HBV infection.
- Further research is needed to elucidate the mechanisms underlying the varying efficacy of interferons in managing chronic HBV infection.
- These findings suggest that therapeutic strategies targeting IFN gamma-R expression are unlikely to improve outcomes for chronic HBV patients unresponsive to IFN gamma.